Bacampicillin

DB01602ApprovedWithdrawnSmall molecule

Bacampicillin is an ampicillin prodrug used to treat various susceptible bacterial infections in the body, such as respiratory infections and skin and subcutaneous tissue infections. It is absorbed following oral administration.

Chemical structure of Bacampicillin
Mechanism
Curator reviewed
Primary indication
For infections at the following sites: upper and lower respiratory tract; skin and soft tissue; urinary tract and acute uncomplicated gonococcal urethritis, when due to sensitive strains of the following organisms: Gram-positive: streptococci (including S....Curator reviewed · 9 structured indications
Formula / weight
C21H27N3O7S · 465.52 g/mol (avg)
First approval
Canada, 2000

Resolves to

Structure
InChIKeyPFOLLRNADZZWEX-FFGRCDKISA-NSMILES[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(=O)OC(C)OC(=O)OCC

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
194Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
9Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
2ContraindicationsEach with its own population and attribute set
Sign in
61Marketed productsAcross 3 countries and 33 labellers
Sign in
2ATC codesIncluding every combination product, plus 13 drug categories
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Bacampicillin, and which companies have late-stage candidates in those indications?

Create a free account or log in to explore the full data card.

Create Account